BETHKIS
tobramycin
- Strength
- 300 mg/4mL
- Form
- Solution
- Class
- Aminoglycoside Antibacterial
Chiesi USA, Inc.
Not stocked by us — reference only
Listed by Fosun Pharma USA Inc
| Dosage form | Injection, Powder, Lyophilized, For Solution |
|---|---|
| Route | Intravenous |
| Drug class | Aminoglycoside Antibacterial |
| Approval route | ANDA — approved generic |
| NDC code | 72266-163 |
| FDA application | ANDA211189 |
| RxNorm concept | 597823 |
| Package sizes listed | 1 |
| Marketed since | August 2021 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
tobramycin
Chiesi USA, Inc.
Not stocked by us — reference only
Tobramycin
Pari Respiratory Equipment, Inc.
Not stocked by us — reference only
Tobramycin
Viatris Specialty LLC
Not stocked by us — reference only
Tobramycin
Viatris Specialty LLC
Not stocked by us — reference only
tobramycin and dexamethasone
Novartis Pharmaceuticals Corporation
Not stocked by us — reference only
tobramycin / dexamethasone
Harrow Eye, LLC
Not stocked by us — reference only
tobramycin / dexamethasone
Eyevance Pharmaceuticals, LLC
Not stocked by us — reference only
Asclemed USA, Inc.
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.